Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 2,005-2,016 of 23,847
Behavioral study icon
RecruitingNCT07299474

Efficacy of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic Procedures

This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

In Los Angeles
AnxietyBehavioralOver 18 Years
Countries
United States
Sponsor
Cedars-Sinai Medical Center
Condition
Anxiety
Other study type icon
RecruitingISRCTN82388279

Efficacy of low-intensity psychological intervention applied by (ICTs) for treatment of depression in primary care

This study is looking at whether a digital support tool can help people with Depression in primary care, Mental and Behavioural Disorders, or Depressive episode, unspecified. Participants take part in a digital support tool and complete follow-up assessments.

In Spain
DepressionOtherOver 18 Years
Countries
Spain
Sponsor
Carlos III Institute of Health (Instituto de Salud Carlos III) (Spain)
Condition
Depression
Device study icon
RecruitingNCT05550155

Efficacy of Maintenance Repetitive Transcranial Magnetic Stimulation (rTMS) in Auditory Verbal Hallucinations

This study is looking at whether Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment can help people with Schizophrenia or Psychosis. Participants take part in Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment and complete follow-up assessments.

In Caen
SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
France
Sponsor
University Hospital, Caen
Condition
Schizophrenia
Drug study icon
RecruitingNCT06707012

Efficacy of Metformin as an Adjunct to Standard Antidepressant Therapy in Treating Depression Among Obese Patients

This study is comparing Metformin Hydrochloride with placebo for people with Depression. Participants receive Metformin Hydrochloride or placebo and complete study visits and assessments.

In Karachi
DepressionDrugA study involving a medication or substance.From 18 Years to 45 Years
Countries
Pakistan
Sponsor
Fazaia Ruth Pfau Medical College
Condition
Depression
Drug study icon
RecruitingISRCTN27649427

Efficacy of mifepristone in the treatment of Depression in bipolarity

This study is looking at care and outcomes for people with Depression in bipolarity or Mental and Behavioural Disorders. Taking part may give some people access to Adjunctive treatment with mifepristone (600 mg/day for 7 days) versus placebo, but direct benefit is not guaranteed.

In United Kingdom
Bipolarity, DepressionOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
The Newcastle, North Tyneside And Northumberland Mental Health NHS Trust (UK)
Condition
Bipolarity, Depression
Behavioral study icon
RecruitingNCT07371988

Efficacy of Narrative Therapy for Older People With Depression

This study is looking at whether a digital support tool can help people with Depression. Participants take part in the program and complete follow-up questionnaires or assessments.

In Kowloon Tong
DepressionBehavioralOver 60 Years
Countries
China
Sponsor
City University of Hong Kong
Condition
Depression
Drug study icon
RecruitingNCT07227818

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

Multiple locations, including Garden Grove
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia
Drug study icon
RecruitingNCT03826693

Efficacy of Nitrous Oxide in OCD: Study

This summary needs review. Please check the official study record and contact the research team for details.

In Stanford
OCDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Stanford University
Condition
OCD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.